4//SEC Filing
Daniell Richard 4
Accession 0000950170-25-035489
CIK 0000818686other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:05 PM ET
Size
13.5 KB
Accession
0000950170-25-035489
Insider Transaction Report
Form 4
Daniell Richard
Exec. VP, European Commercial
Transactions
- Exercise/Conversion
Restricted Share Units
2025-03-05−22,576→ 0 total→ Ordinary Shares (22,576 underlying) - Exercise/Conversion
Ordinary Shares
2025-03-05+22,576→ 119,345 total - Sale
Ordinary Shares
2025-03-05$15.91/sh−22,576$359,272→ 96,769 total - Sale
Ordinary Shares
2025-03-05$15.90/sh−48,385$769,370→ 48,384 total - Award
Restricted Share Units
2025-03-05+69,182→ 69,182 total→ Ordinary Shares (69,182 underlying)
Footnotes (7)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.795 to $16.01, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.9 to $15.905, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]Restricted share units were granted on March 5, 2021, with 22,576 vested on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025.
- [F7]Restricted share units were granted on March 5, 2025, with 17,295 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001726096
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:05 PM ET
- Size
- 13.5 KB